Panacea Biotec receives LoA from UNICEF for supply of 115 million doses of bOPV

Panacea Biotec Limited ("the Company") has received a Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025.

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 434.55 as compared to the previous close of Rs. 429.35. The total number of shares traded during the day was 8948 in over 225 trades.

The stock hit an intraday high of Rs. 446.95 and intraday low of 410.00. The net turnover during the day was Rs. 3765458.00.

Source : Equity Bulls

Keywords

PanaceaBiotec INE922B01023 LoA UNICEF bOPVSupply